Fishman Corey N. 4
4 · Iterum Therapeutics plc · Filed Jun 25, 2021
Insider Transaction Report
Form 4
Fishman Corey N.
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2021-06-23+5,280,000→ 5,280,000 totalExercise: $2.01Exp: 2031-06-22→ Ordinary Shares (5,280,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of June 23, 2021 and the remaining 75% will vest in equal monthly installments thereafter until June 23, 2025, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.